Cardlytics Inc

Company Profile

Cardlytics Inc had its IPO on 2018-02-09 under the ticker symbol CDLX.

The company operates in the Communication Services sector and Advertising Agencies industry. Cardlytics Inc has a staff strength of 501 employees.

Stock update

Shares of Cardlytics Inc opened at $3.31 at the start of the last trading session i.e. 2023-03-19.

The stocks traded within a range of $3.07 - $3.32, and closed at $3.12.

This is a -7.42% slip from the previous day's closing price.

A total volume of 1,022,700 shares were traded at the close of the day’s session.

In the last one week, shares of Cardlytics Inc have slipped by -24.82%.

Cardlytics Inc's Key Ratios

Cardlytics Inc has a market cap of $113.25 million, indicating a price to book ratio of 0.3405 and a price to sales ratio of 0.6371.

In the last 12-months Cardlytics Inc’s revenue was $298.54 million with a gross profit of $115.42 million and an EBITDA of $-89211000. The EBITDA ratio measures Cardlytics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Cardlytics Inc’s operating margin was -42.46% while its return on assets stood at -8.1% with a return of equity of -103.13%.

In Q4, Cardlytics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 8.4%.

Cardlytics Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-11.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Cardlytics Inc’s profitability.

Cardlytics Inc stock is trading at a EV to sales ratio of 0.9672 and a EV to EBITDA ratio of -5.2971. Its price to sales ratio in the trailing 12-months stood at 0.6371.

Cardlytics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$691.24 million

Total Liabilities

$248.94 million

Operating Cash Flow

$-3153000.00

Capital Expenditure

$2.98 million

Dividend Payout Ratio

0%

Cardlytics Inc ended 2023 with $691.24 million in total assets and $0 in total liabilities. Its intangible assets were valued at $691.24 million while shareholder equity stood at $211.61 million.

Cardlytics Inc ended 2023 with $0 in deferred long-term liabilities, $248.94 million in other current liabilities, 9000.00 in common stock, $-976570000.00 in retained earnings and $352.72 million in goodwill. Its cash balance stood at $121.91 million and cash and short-term investments were $121.91 million. The company’s total short-term debt was $4,910,000 while long-term debt stood at $226.05 million.

Cardlytics Inc’s total current assets stands at $250.04 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $120.08 million compared to accounts payable of $3.77 million and inventory worth $0.

In 2023, Cardlytics Inc's operating cash flow was $-3153000.00 while its capital expenditure stood at $2.98 million.

Comparatively, Cardlytics Inc paid $0 in dividends in 2023.

Other key metrics

Current Trading Price

$3.12

52-Week High

$62.9

52-Week Low

$3.074

Analyst Target Price

$5.5

Cardlytics Inc stock is currently trading at $3.12 per share. It touched a 52-week high of $62.9 and a 52-week low of $62.9. Analysts tracking the stock have a 12-month average target price of $5.5.

Its 50-day moving average was $5.68 and 200-day moving average was $10.66 The short ratio stood at 5.52 indicating a short percent outstanding of 0%.

Around 280.6% of the company’s stock are held by insiders while 8972.5% are held by institutions.